Dexcom
ProfileJobs

Dexcom

Suggest Edit
    • Healthdiabetesmedtechmonitoringwearables

    Dexcom, Inc. is a company that develops, manufactures and distributes continuous glucose monitoring systems for diabetes management. The Company provides Dexcom Seven that can show a new glucose reading every 5 minutes for up to seven days of uninterrupted wear-time to show where glucose levels are, where they have been and where they are going. The system is made up of three technologies: the sensor, transmitter, and receiver. The sensor is a flexible round wire that goes just under the skin to read glucose levels, and attaches to the skin with an adhesive patch. The transmitter snaps into the sensor; it wirelessly sends glucose information to the Receiver every 5 minutes. The receiver displays glucose levels and trends.

    Revenue(FY, 2016)
    $573.3 M
    Market capitalization(2018-05-25)
    $7.8 B
    Type
    Public
    HQ
    San Diego, US
    Founded
    1999
    Size (employees)
    1,900 (est)
    Website
    dexcom.com
    Dexcom was founded in 1999 and is headquartered in San Diego, US
    Report incorrect company information

    Key People/Management at Dexcom

    Terrance Gregg

    Terrance Gregg

    Executive Chairman
    Kevin Sayer

    Kevin Sayer

    CEO & President
    Andrew Balo

    Andrew Balo

    EVP, Clinical Affairs, Regulatory Strategies, and Global Access
    Rick Doubleday

    Rick Doubleday

    EVP, Chief Commercial Officer
    Jake Leach

    Jake Leach

    SVP, Research & Development
    John Lister

    John Lister

    GM, Europe, Middle East & Africa
    Show more

    Dexcom Office Locations

    Dexcom has an office in San Diego
    San Diego, US (HQ)
    6340 Sequence Dr
    Show all (1)
    Report incorrect company information

    Dexcom Financials and Metrics

    Dexcom Financials

    Dexcom's revenue was reported to be $573.30 m in FY, 2016 which is a 42.6% increase from the previous period.
    USD

    Revenue (Q3, 2017)

    		184.6 m

    Gross profit (Q3, 2017)

    		127 m

    Gross profit margin (Q3, 2017), %

    		68.8%

    Net income (Q3, 2017)

    		(2 m)

    EBIT (Q3, 2017)

    		(500 k)

    Market capitalization (25-May-2018)

    		7.8 b

    Closing share price (25-May-2018)

    		88

    Cash (30-Sep-2017)

    		402.1 m
    Dexcom's current market capitalization is $7.8 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Revenue

    		160 m259.2 m402 m573.3 m

    Revenue growth, %

    		62%55%43%

    Cost of goods sold

    		59.9 m82.9 m123.6 m194.9 m

    Gross profit

    		100.1 m176.3 m278.4 m378.4 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    		42.9 m47.1 m58.8 m69 m72.8 m93.2 m105.2 m116.2 m137.3 m148.6 m142.3 m170.6 m184.6 m

    Cost of goods sold

    		15.3 m17.3 m18.9 m21.8 m26.3 m27.2 m30.5 m41.1 m51.8 m47.5 m48.2 m53.1 m57.6 m

    Gross profit

    		27.6 m29.8 m39.9 m47.2 m46.5 m66 m74.7 m75.1 m85.5 m101.1 m94.1 m117.5 m127 m

    Gross profit Margin, %

    		64%63%68%68%64%71%71%65%62%68%66%69%69%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    		43.2 m71.8 m86.1 m94.5 m

    Accounts Receivable

    		26.1 m42.4 m74.1 m101.7 m

    Inventories

    		9 m16 m35.2 m45.4 m

    Current Assets

    		93.1 m145.9 m231.3 m280 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cash

    		33.4 m45.7 m49.5 m63.2 m54.2 m67.7 m85.3 m77.9 m87.5 m97.7 m153.5 m395.9 m402.1 m

    Accounts Receivable

    		21.6 m23.8 m28.6 m31.4 m40.2 m45.5 m55.8 m85.9 m101.7 m110.5 m

    Inventories

    		10 m8.9 m11.6 m14.3 m18.4 m22.4 m30.6 m46.1 m42.9 m44.7 m46.5 m42.8 m43.3 m

    Current Assets

    		81.7 m93.6 m105.5 m123.4 m146.2 m170.4 m203.7 m227.4 m241 m258.6 m330.5 m656.8 m692.9 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		(29.8 m)(22.4 m)(57.6 m)(65.6 m)

    Depreciation and Amortization

    		7 m8.4 m10.8 m15 m

    Inventories

    		(1.6 m)(7 m)(19 m)(9.8 m)

    Cash From Operating Activities

    		2.4 m23.6 m49 m56.2 m92 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    		(27.2 m)(12.5 m)(18.5 m)(23.7 m)(12.9 m)(16.6 m)(59.1 m)(19.2 m)(39.4 m)(58.2 m)(41.7 m)(38.8 m)(40.8 m)

    Depreciation and Amortization

    		5.1 m1.9 m3.8 m6 m2.4 m5 m7.7 m3.4 m7.3 m11.4 m3.7 m7.6 m11.9 m

    Inventories

    		(2.5 m)200 k(2.6 m)(5.3 m)(2.4 m)(6.4 m)(14.6 m)(10.9 m)(7.2 m)(8.9 m)(1 m)2.8 m2.2 m

    Cash From Operating Activities

    		(2 m)(2.4 m)3.8 m15.2 m3.4 m19.8 m37.7 m(200 k)19.9 m42.9 m300 k14.6 m50.8 m
    show all
    USDY, 2017

    Revenue/Employee

    		97.2 k

    Financial Leverage

    		2.2 x
    Show all financial metrics

    Dexcom Operating Metrics

    FY, 2016

    Patents (foreign)

    		48

    Patents Pending

    		417

    Trademarks (US)

    		24

    Trademarks (foreign)

    		54
    Show all operating metrics
    Report incorrect company information

    Competitors

    Glooko
    Health - Private
    Hinge Health
    Health - Private
    Spry Health
    Health - Private
    ActiveCare
    Health - Public
    Compare competitors

    Dexcom News and Updates

    February 23, 2018

    Blood Glucose Meter Market Business Outlook and Key Manufacturers Report 2018

    This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies Posted via Industry Today. Follow us on Twitter @IndustryToday
    January 25, 2018

    Worldwide Artificial Pancreas Market Multiply Relentlessly; Asserts MRFR Unleashing Industry Forecast - 2023

    Market research future has a half cooked research report on global Artificial Pancreas market. The global Artificial Pancreas market is growing rapidly by 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
    October 12, 2017

    POC Blood Glucose Monitoring Devices Market 2017 Global Manufactures : Cercacor, OrSense, Dexcom and Terumo

    Market Research Store added a depth and professional market study report on Global POC Blood Glucose Monitoring Devices Market 2017. This report also provides more details about Market Size, Share, Analysis, import/export consumption, supply and demand Figures, cost, price, revenue and gross margins…
    September 22, 2017

    Global Diabetes Care Devices Market sales is growing at 5.9% CAGR till 2022

    Global diabetic care device market expected to reach USD 26.00 billion by 2021, growing at a CAGR of 5.9% between 2016 and 2021. Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF